Cancer pharmacology examines the development and use of drugs to treat malignancies, while cancer toxicology evaluates their safety and side effects. The field includes chemotherapy, targeted therapies, immunotherapies, and hormone-based treatments. Researchers focus on mechanisms of action, resistance, and combination regimens to improve survival rates. Cancer toxicology addresses dose-limiting toxicities, organ damage, and secondary malignancies caused by therapy. Advances in molecular oncology and biomarker-guided treatments are driving personalized cancer care. Safety evaluation remains essential to balance therapeutic benefits with potential harm.
sub tracks:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
